Bioicus Lab
← Back to Bioicus Lab
Early-stage life science ventures face a painful choice: hire an expensive, qualified full-time Product Manager too early and burn cash during long R&D cycles, or wait too long with complicated hiring processes and miss a critical commercial window while your investors are waiting for results.
Most spinouts can't justify £100k+ for a role that sits partially idle during 6-12 month experiments.
But without strategic guidance, R&D can make outstanding scientific products, with the risk that there is no market for them.
"I discovered this in the life science industry. A full-time product management intensity doesn't match the early biotech's rhythmic reality. The Idle Valley is real, and it costs companies thousands in misallocated resources, when being lean and fast is most critical."
The solution to the Idle Valley is fractional Product Management — strategic guidance that matches the natural Product BioRhythm of your R&D cycles. Instead of flat investment when you need burst intensity, you get expert support precisely when critical decisions are made.
Start with the Product BioRhythm™ Diagnostic to assess your technology readiness, market opportunity, and competitive position using industry-standard frameworks. You'll receive general recommendations on your current phase and potential next steps.
Detailed Technology Readiness Level scoring with specific recommendations for advancement
TAM/SAM/SOM analysis for your specific technology and target segments
Visual competitive landscape showing your position vs alternatives
Limited spots for initial cohort. We'll review and contact qualified applicants within 48 hours.
Methodology validated in MBA research on ML adoption in life sciences.
University of Winchester, 2023 • n=213 professionals
Limited early access spots available. Corporate email required.
Request Early Access ↑